Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II)in patients with advanced adenocarcinoma of the lung

R. T. Eagan, S. Frytak, J. N. Ingle, E. T. Creagan, W. C. Nichols, L. K. Kvols

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II)in patients with advanced adenocarcinoma of the lung'. Together they form a unique fingerprint.

Medicine & Life Sciences